CGM-Derived Metrics Show Variable Associations With CVD Tags Continuous glucose monitoring (CGM) Read more about CGM-Derived Metrics Show Variable Associations With CVD
GLP-1 Therapy Lowered MACE and Hypoglycemia Risk in T1DM Tags Coronary artery disease Myocardial infarction GLP-1 agonists Read more about GLP-1 Therapy Lowered MACE and Hypoglycemia Risk in T1DM
AACE 2026: Common AEs Seen With Teplizumab in Stage 2 and 3 T1DM Read more about AACE 2026: Common AEs Seen With Teplizumab in Stage 2 and 3 T1DM
GLP-1 RAs in T1DM Show No Increased Severe Hypoglycemia or DKA Tags Diabetic ketoacidosis Hypoglycemia GLP-1 agonists Read more about GLP-1 RAs in T1DM Show No Increased Severe Hypoglycemia or DKA
Higher HbA1c Threshold May Better Stratify Adult T1DM Risk Tags hBA1c Read more about Higher HbA1c Threshold May Better Stratify Adult T1DM Risk
T Cell Immunotherapy Preserves β-Cell Function in New-Onset T1DM Read more about T Cell Immunotherapy Preserves β-Cell Function in New-Onset T1DM
Early AID Adoption in New-Onset T1DM Shows Low Hypoglycemia Burden Tags Diabetic ketoacidosis Hypoglycemia Insulin Pumps Others Delivery devices Continuous glucose monitoring (CGM) Read more about Early AID Adoption in New-Onset T1DM Shows Low Hypoglycemia Burden
AACE 2026: Inpatient Glycemia Improves With Insulin Pump Continuation Tags Hypoglycemia Insulin Pumps Read more about AACE 2026: Inpatient Glycemia Improves With Insulin Pump Continuation
Prolonged Glucose Excursions Drive GMI-HbA1c Discordance in T1DM Tags hBA1c Continuous glucose monitoring (CGM) Read more about Prolonged Glucose Excursions Drive GMI-HbA1c Discordance in T1DM
Adolescent Perspectives Highlight Low Burden With SGLT2i Adjunct Therapy Tags SGLT-2 Inhibitor Read more about Adolescent Perspectives Highlight Low Burden With SGLT2i Adjunct Therapy